PRTC
Price
$19.00
Change
+$0.40 (+2.15%)
Updated
Jun 6 closing price
Capitalization
456.97M
17 days until earnings call
RLMD
Price
$0.83
Change
+$0.01 (+1.22%)
Updated
Jun 6 closing price
Capitalization
27.71M
66 days until earnings call
Interact to see
Advertisement

PRTC vs RLMD

Header iconPRTC vs RLMD Comparison
Open Charts PRTC vs RLMDBanner chart's image
PureTech Health
Price$19.00
Change+$0.40 (+2.15%)
Volume$1.13K
Capitalization456.97M
Relmada Therapeutics
Price$0.83
Change+$0.01 (+1.22%)
Volume$477.71K
Capitalization27.71M
PRTC vs RLMD Comparison Chart
Loading...
RLMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PRTC vs. RLMD commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PRTC is a Hold and RLMD is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 07, 2025
Stock price -- (PRTC: $19.00 vs. RLMD: $0.83)
Brand notoriety: PRTC and RLMD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PRTC: 18% vs. RLMD: 21%
Market capitalization -- PRTC: $456.97M vs. RLMD: $27.71M
PRTC [@Biotechnology] is valued at $456.97M. RLMD’s [@Biotechnology] market capitalization is $27.71M. The market cap for tickers in the [@Biotechnology] industry ranges from $324.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PRTC’s FA Score shows that 0 FA rating(s) are green whileRLMD’s FA Score has 1 green FA rating(s).

  • PRTC’s FA Score: 0 green, 5 red.
  • RLMD’s FA Score: 1 green, 4 red.
According to our system of comparison, RLMD is a better buy in the long-term than PRTC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RLMD’s TA Score shows that 5 TA indicator(s) are bullish.

  • RLMD’s TA Score: 5 bullish, 4 bearish.

Price Growth

PRTC (@Biotechnology) experienced а +3.09% price change this week, while RLMD (@Biotechnology) price change was +11.32% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.04%. For the same industry, the average monthly price growth was +14.90%, and the average quarterly price growth was +1.90%.

Reported Earning Dates

PRTC is expected to report earnings on Aug 27, 2025.

RLMD is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+9.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRTC($457M) has a higher market cap than RLMD($27.7M). RLMD YTD gains are higher at: 60.558 vs. PRTC (2.925). PRTC has higher annual earnings (EBITDA): -53.65M vs. RLMD (-91.64M). PRTC has more cash in the bank: 502M vs. RLMD (54.1M). RLMD has less debt than PRTC: RLMD (256K) vs PRTC (24M). PRTC (0) and RLMD (0) have equivalent revenues.
PRTCRLMDPRTC / RLMD
Capitalization457M27.7M1,650%
EBITDA-53.65M-91.64M59%
Gain YTD2.92560.5585%
P/E Ratio9.05N/A-
Revenue00-
Total Cash502M54.1M928%
Total Debt24M256K9,375%
FUNDAMENTALS RATINGS
RLMD: Fundamental Ratings
RLMD
OUTLOOK RATING
1..100
24
VALUATION
overvalued / fair valued / undervalued
1..100
23
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RLMD
RSI
ODDS (%)
Bearish Trend 1 day ago
85%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
80%
Momentum
ODDS (%)
Bullish Trend 1 day ago
79%
MACD
ODDS (%)
Bullish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
81%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
80%
Advances
ODDS (%)
Bullish Trend 1 day ago
83%
Declines
ODDS (%)
Bearish Trend 4 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
76%
View a ticker or compare two or three
Interact to see
Advertisement
RLMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DFDSX23.780.12
+0.51%
DF Dent Small Cap Growth Investor
WPLCX15.61N/A
N/A
WP Large Cap Income Plus Institutional
JSGAX27.08N/A
N/A
JHancock U.S. Growth A
TGIWX14.80N/A
N/A
Nuveen Core Equity W
LGOSX26.81N/A
N/A
Lord Abbett Growth Opportunities R4

PRTC and

Correlation & Price change

A.I.dvisor tells us that PRTC and AUTL have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PRTC and AUTL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRTC
1D Price
Change %
PRTC100%
+2.15%
AUTL - PRTC
32%
Poorly correlated
+3.54%
RLMD - PRTC
31%
Poorly correlated
+1.82%
PTCHF - PRTC
29%
Poorly correlated
N/A
ZLAB - PRTC
28%
Poorly correlated
+4.30%
IRON - PRTC
27%
Poorly correlated
+5.71%
More

RLMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, RLMD has been loosely correlated with SYRE. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if RLMD jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RLMD
1D Price
Change %
RLMD100%
+1.82%
SYRE - RLMD
36%
Loosely correlated
+2.11%
ENTO - RLMD
36%
Loosely correlated
+5.69%
PRTC - RLMD
31%
Poorly correlated
+2.15%
AVXL - RLMD
31%
Poorly correlated
+6.30%
ZVRA - RLMD
29%
Poorly correlated
+4.87%
More